MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-06-2025
OrthoPediatrics Corp. DPO Ratio 2011-2025 | KIDS
Annual DPO Ratio OrthoPediatrics Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.1 | 116 | 118 | 143 | 188 | 132 | 97.4 | 180 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 188 | 70.1 | 130 |
Quarterly DPO Ratio OrthoPediatrics Corp.
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.9 | 83.3 | 90.1 | 140 | 154 | 220 | 180 | 158 | - | 54.8 | 83.7 | 225 | - | 134 | 162 | 196 | - | 201 | 259 | 182 | - | 122 | 129 | 119 | - | 94.3 | 95.2 | 136 | 56.8 | 52.8 | 162 | 176 | 50.5 | 54.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 259 | 50.5 | 132 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
35.1 | $ 10.27 | -1.25 % | $ 1.37 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Abiomed
ABMD
|
76.2 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.81 | -1.3 % | $ 132 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 304.24 | -1.26 % | $ 8.58 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 45.22 | 0.2 % | $ 6.74 K | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 128.77 | 2.63 % | $ 224 B | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 91.99 | -0.63 % | $ 135 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.08 | 6.94 % | $ 115 M |  France |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 9.69 | -1.77 % | $ 696 M | Israel |
 |
InMode Ltd.
INMD
|
65.1 | $ 14.38 | -0.93 % | $ 1.14 B | Israel |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 164.09 | -0.81 % | $ 12.3 B | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 0.96 | 4.25 % | $ 15.5 M | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 96.61 | 0.39 % | $ 1.22 B | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 1.06 | -0.47 % | $ 109 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 12.7 | -0.06 % | $ 343 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 14.81 | 0.41 % | $ 97.1 M | USA |
 |
AxoGen
AXGN
|
79.6 | $ 29.91 | -1.58 % | $ 1.32 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 40.19 | -1.56 % | $ 1.24 B | USA |
 |
Globus Medical
GMED
|
23.2 | $ 86.2 | -0.57 % | $ 11.7 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 13.57 | 1.12 % | $ 1.05 B | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
99.4 | $ 20.02 | 0.28 % | $ 2.86 B | USA |
 |
LivaNova PLC
LIVN
|
71.8 | $ 62.86 | 0.18 % | $ 3.41 B |  Britain |
|
LENSAR
LNSR
|
66 | $ 11.6 | 0.78 % | $ 134 M | USA |
 |
Aethlon Medical
AEMD
|
61.8 | $ 3.22 | -5.29 % | $ 5.03 M | USA |